Freyja Lynn

1.5k total citations · 1 hit paper
16 papers, 1.1k citations indexed

About

Freyja Lynn is a scholar working on Microbiology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Freyja Lynn has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Microbiology, 9 papers in Epidemiology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Freyja Lynn's work include Bacterial Infections and Vaccines (12 papers), Pneumonia and Respiratory Infections (8 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Freyja Lynn is often cited by papers focused on Bacterial Infections and Vaccines (12 papers), Pneumonia and Respiratory Infections (8 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Freyja Lynn collaborates with scholars based in United States, Gambia and Mali. Freyja Lynn's co-authors include Bruce D. Meade, George F. Reed, Margaret C. Bash, Carl E. Frasch, Andrew L. Baughman, Che‐Hung Lee, David Berry, Kristine M. Bisgard, Kathy L. Holland and Kathryn M. Edwards and has published in prestigious journals such as PEDIATRICS, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

Freyja Lynn

16 papers receiving 1.1k citations

Hit Papers

Use of Coefficient of Variation in Assessing Variability ... 2002 2026 2010 2018 2002 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Use of Coefficient of Variation in Assessing Variability of Quantitative Assays
    2002 540 citations George F. Reed, Freyja Lynn et al. Clinical and Vaccine Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Freyja Lynn United States 14 325 318 247 137 85 16 1.1k
Tatsuo Kato Japan 16 153 0.5× 278 0.9× 140 0.6× 64 0.5× 36 0.4× 109 1.2k
Anthony Almudevar United States 23 196 0.6× 380 1.2× 273 1.1× 75 0.5× 84 1.0× 81 1.4k
Michael Hagmann Austria 22 120 0.4× 508 1.6× 534 2.2× 74 0.5× 32 0.4× 94 1.8k
Ikuo Kobayashi Japan 23 128 0.4× 190 0.6× 221 0.9× 85 0.6× 123 1.4× 188 1.9k
David Griffiths Australia 27 123 0.4× 240 0.8× 256 1.0× 93 0.7× 46 0.5× 90 2.2k
Hwa Jin Cho South Korea 20 82 0.3× 362 1.1× 193 0.8× 55 0.4× 261 3.1× 130 1.5k
Peter Larsson Sweden 25 259 0.8× 807 2.5× 386 1.6× 279 2.0× 53 0.6× 111 2.6k
William C. Ray United States 18 289 0.9× 501 1.6× 344 1.4× 196 1.4× 38 0.4× 56 1.2k
Amit Patel United States 26 116 0.4× 194 0.6× 245 1.0× 78 0.6× 50 0.6× 107 2.6k
Pardeep Khanna India 17 51 0.2× 373 1.2× 290 1.2× 162 1.2× 49 0.6× 80 1.7k

Countries citing papers authored by Freyja Lynn

Since Specialization
Citations

This map shows the geographic impact of Freyja Lynn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Freyja Lynn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Freyja Lynn more than expected).

Fields of papers citing papers by Freyja Lynn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Freyja Lynn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Freyja Lynn. The network helps show where Freyja Lynn may publish in the future.

Co-authorship network of co-authors of Freyja Lynn

This figure shows the co-authorship network connecting the top 25 collaborators of Freyja Lynn. A scholar is included among the top collaborators of Freyja Lynn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Freyja Lynn. Freyja Lynn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bash, Margaret C., Freyja Lynn, Ray Borrow, et al.. (2014). Development and Use of a Serum Bactericidal Assay Using Pooled Human Complement To Assess Responses to a Meningococcal Group A Conjugate Vaccine in African Toddlers. Clinical and Vaccine Immunology. 21(5). 755–761. 13 indexed citations
2.
Fay, Michael P., Dean Follmann, Freyja Lynn, et al.. (2012). Anthrax Vaccine–Induced Antibodies Provide Cross-Species Prediction of Survival to Aerosol Challenge. Science Translational Medicine. 4(151). 151ra126–151ra126. 43 indexed citations
3.
Arciniega, Juan, et al.. (2011). Target alternative vaccine safety testing strategies for pertussis toxin. 5. 248–260. 10 indexed citations
4.
Madore, Dace V., et al.. (2010). Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: Meeting at the Crossroads. Vaccine. 28(29). 4539–4547. 28 indexed citations
5.
Omland, Kristian Shawn, et al.. (2008). Interlaboratory Comparison of Results of an Anthrax Lethal Toxin Neutralization Assay for Assessment of Functional Antibodies in Multiple Species. Clinical and Vaccine Immunology. 15(6). 946–953. 31 indexed citations
6.
Baughman, Andrew L., Kristine M. Bisgard, Freyja Lynn, & Bruce D. Meade. (2005). Mixture model analysis for establishing a diagnostic cut-off point for pertussis antibody levels. Statistics in Medicine. 25(17). 2994–3010. 28 indexed citations
7.
Bash, Margaret C., et al.. (2005). por Variable-Region Typing by DNA Probe Hybridization Is Broadly Applicable to Epidemiologic Studies of Neisseria gonorrhoeae. Journal of Clinical Microbiology. 43(4). 1522–1530. 15 indexed citations
8.
Lynn, Freyja, Marcia M. Hobbs, Jonathan M. Zenilman, et al.. (2005). Genetic Typing of the Porin Protein of Neisseria gonorrhoeae from Clinical Noncultured Samples for Strain Characterization and Identification of Mixed Gonococcal Infections. Journal of Clinical Microbiology. 43(1). 368–375. 31 indexed citations
9.
Baughman, Andrew L., Kristine M. Bisgard, Kathryn M. Edwards, et al.. (2004). Establishment of Diagnostic Cutoff Points for Levels of Serum Antibodies to Pertussis Toxin, Filamentous Hemagglutinin, and Fimbriae in Adolescents and Adults in the United States. Clinical and Vaccine Immunology. 11(6). 1045–1053. 109 indexed citations
10.
Reed, George F., Freyja Lynn, & Bruce D. Meade. (2003). Use of Coefficient of Variation in Assessing Variability of Quantitative Assays. Clinical and Vaccine Immunology. 10(6). 1162–1162. 104 indexed citations
11.
Lynn, Freyja, et al.. (2003). Porin Variation among Clinical Isolates ofNeisseria gonorrhoeaeover a 10‐Year Period, as Determined byPorVariable Region Typing. The Journal of Infectious Diseases. 187(8). 1213–1222. 30 indexed citations
12.
Reed, George F., Freyja Lynn, & Bruce D. Meade. (2002). Use of Coefficient of Variation in Assessing Variability of Quantitative Assays. Clinical and Vaccine Immunology. 9(6). 1235–1239. 540 indexed citations breakdown →
13.
Berry, David, Freyja Lynn, Che‐Hung Lee, Carl E. Frasch, & Margaret C. Bash. (2002). Effect of O Acetylation of Neisseria meningitidis Serogroup A Capsular Polysaccharide on Development of Functional Immune Responses. Infection and Immunity. 70(7). 3707–3713. 105 indexed citations
14.
Bash, Margaret C., Freyja Lynn, Nelydia F. Concepcion, et al.. (2000). Genetic and immunologic characterization of a novel serotype 4, 15 strain ofNeisseria meningitidis. FEMS Immunology & Medical Microbiology. 29(3). 169–176. 7 indexed citations
15.
Meade, Bruce D., et al.. (1995). Description and Evaluation of Serologic Assays Used in a Multicenter Trial of Acellular Pertussis Vaccines. PEDIATRICS. 96(6). A48–A48. 36 indexed citations
16.
Meade, Bruce D., Freyja Lynn, George F. Reed, et al.. (1995). Relationships Between Functional Assays and Enzyme Immunoassays as Measurements of Responses to Acellular and Whole-Cell Pertussis Vaccines. PEDIATRICS. 96(6). A48–A48. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tatsuo Kato Breakdown of academic impact, for papers by Anthony Almudevar Breakdown of academic impact, for papers by Michael Hagmann Breakdown of academic impact, for papers by Ikuo Kobayashi Breakdown of academic impact, for papers by David Griffiths Breakdown of academic impact, for papers by Hwa Jin Cho Breakdown of academic impact, for papers by Peter Larsson Breakdown of academic impact, for papers by William C. Ray Breakdown of academic impact, for papers by Amit Patel Breakdown of academic impact, for papers by Pardeep Khanna
Rankless by CCL
2026